版本:
中国

BRIEF-Adverum Biotechnologies says delivered notice to Regenxbio

April 21 Adverum Biotechnologies Inc:

* Adverum Biotechnologies - on april 19, co delivered a notice to Regenxbio Inc to terminate license agreement dated october 20, 2015 - sec filing

* License agreement, dated october 20, 2015, is between Regenxbio and Annapurna Therapeutics Limited

* Adverum Biotechnologies-does not expect license agreement termination to affect development of advm-043 product candidate for alpha-1 antitrypsin deficiency Source text - bit.ly/2ouYKGd Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐